These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2604595)

  • 1. Influence of high and low wall shear rates on the inhibition of factor Xa and thrombin at surfaces coated with immobilized heparin.
    Arnander C; Pasche B; Kodama K; Rasmuson A; Olsson P
    Artif Organs; 1989 Dec; 13(6):521-6. PubMed ID: 2604595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of blood coagulation at heparin-coated surfaces.
    Blezer R; Fouache B; Willems GM; Lindhout T
    J Biomed Mater Res; 1997 Oct; 37(1):108-13. PubMed ID: 9335355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics of anticoagulation by covalently immobilized heparin.
    Miura Y; Aoyagi S; Kusada Y; Miyamoto K
    J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant activity of artificial biomedical materials with co-immobilized antithrombin III and heparin.
    Miura Y; Aoyagi S; Ikeda F; Miyamoto K
    Biochimie; 1980; 62(8-9):595-601. PubMed ID: 7417594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III binding to surface immobilized heparin and its relation to F Xa inhibition.
    Kodama K; Pasche B; Olsson P; Swedenborg J; Adolfsson L; Larm O; Riesenfeld J
    Thromb Haemost; 1987 Dec; 58(4):1064-7. PubMed ID: 3481885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term stability in vivo of a thromboresistant heparinized surface.
    Arnander C; Bagger-Sjöbäck D; Frebelius S; Larsson R; Swedenborg J
    Biomaterials; 1987 Nov; 8(6):496-9. PubMed ID: 3427150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
    Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
    Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systems.
    Kaiser B; Callas D; Hoppensteadt D; Mallinowska K; Fareed J
    Thromb Res; 1994 Mar; 73(5):327-35. PubMed ID: 8016817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of blood flow and the effect of protamine on the thromboresistant properties of a covalently bonded heparin surface.
    Arnander C; Olsson P; Larm O
    J Biomed Mater Res; 1988 Oct; 22(10):859-68. PubMed ID: 3220839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patency of heparin-PVA coated tubes at low flow rates.
    Ip WF; Sefton MV
    Biomaterials; 1989 Jul; 10(5):313-7. PubMed ID: 2765627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin activity of surface-bound heparin studied under flow conditions.
    Lindhout T; Blezer R; Schoen P; Willems GM; Fouache B; Verhoeven M; Hendriks M; Cahalan L; Cahalan PT
    J Biomed Mater Res; 1995 Oct; 29(10):1255-66. PubMed ID: 8557728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin inactivation on surfaces with covalently bonded heparin.
    Pasche B; Kodama K; Larm O; Olsson P; Swedenborg J
    Thromb Res; 1986 Dec; 44(6):739-48. PubMed ID: 3798418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin immobilization onto segmented polyurethane-urea surfaces--effect of hydrophilic spacers.
    Park KD; Okano T; Nojiri C; Kim SW
    J Biomed Mater Res; 1988 Nov; 22(11):977-92. PubMed ID: 3241011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of TFPI on thrombin and factor Xa generation in vitro--modulatory action of glycosaminoglycans.
    Kaiser B; Hoppensteadt DA; Jeske W; Wun TC; Fareed J
    Thromb Res; 1994 Sep; 75(6):609-16. PubMed ID: 7831680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH; Bondeli C; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor Xa inactivation by a heparinized hydrogel.
    Rollason G; Sefton MV
    Thromb Res; 1986 Nov; 44(4):517-25. PubMed ID: 3798412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
    Buchanan MR; Brister SJ
    Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.